BioCentury
ARTICLE | Financial News

AnTolRx completes venture financing

September 12, 2016 7:00 AM UTC

AnTolRx Inc., Business: Endocrine/Metabolic, Autoimmune Date completed: 2016-09-08 Type: Venture financing Raised: $4 million Investors: Pfizer Inc.; Orion Equity Partners LLC; Juvenile Diabetes Res...